학술논문
Radiotherapy with Durvalumab vs. Cetuximab in Patients with Locoregionally Advanced Head and Neck Cancer and a Contraindication to Cisplatin: Phase II Results of NRG-HN004
Document Type
Abstract
Author
Source
In International Journal of Radiation Oncology, Biology, Physics 1 December 2022 114(5):1058-1058
Subject
Language
ISSN
0360-3016